Efficient and Scalable Enantioselective Synthesis of a Key Intermediate for Rimegepant: An Oral CGRP Receptor Antagonist

Affiliations

Zhonghua Luo: The State Key Laboratory of Anti-Infective Drug Development, Sunshine Lake Pharma Co., Ltd, Dongguan, People's Republic of China
Guodong Sun: The State Key Laboratory of Anti-Infective Drug Development, Sunshine Lake Pharma Co., Ltd, Dongguan, People's Republic of China
Guowei Wang: Process Research & Development, HEC API Yichang Co., Ltd., Yichang, People's Republic of China
Xin Zhang: Process Research & Development, HEC API Yichang Co., Ltd., Yichang, People's Republic of China
Yang Zhang: Process Research & Development, HEC API Yichang Co., Ltd., Yichang, People's Republic of China
Ji Zhang: The State Key Laboratory of Anti-Infective Drug Development, Sunshine Lake Pharma Co., Ltd, Dongguan, People's Republic of China

Abstract

No abstracts available.

ISSN: 2628-5088 (Print); 2628-5096 (Online)
Publisher: Georg Thieme Verlag KG
Country of publisher: Germany
LCC subjects: Medicine: Pharmacy and materia medica
Website: https://www.thieme.com/books-main/chemistry/product/5416-pharmaceutical-fronts